tiprankstipranks
pc:genra

GenrAb Inc

Therapeutics
GenrAb Inc. is a biotechnology company focused on developing first-in-class neuroprotective therapies. The company is advancing its lead candidate, TGM-010, a fully-human neuroprotective antibody designed to cross the blood-brain barrier and engage neuronal stress management mechanisms to mitigate neurological disabilities. GenrAb is building a pipeline of innovative neurotherapeutic antibodies aimed at addressing unmet medical needs in neurology.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$6M
Total Amount Raised$6M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$6M
Latest Funding Amount$6M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 22, 2025
Seed Round
$5.60M
―

Related News and Analysis

Cylake Forms High-Profile Board, Secures In-Q-Tel Backing to Advance Sovereign Cyber Platform

Cylake Forms High-Profile Board, Secures In-Q-Tel Backing to Advance Sovereign Cyber Platform

New updates have been reported about Cylake. Cylake has established a new board of directors and secured a...
2d ago
CYLAK
Emovid Launches Verified Human Communication Platform to Counter Synthetic Media Risks

Emovid Launches Verified Human Communication Platform to Counter Synthetic Media Risks

New updates have been reported about Emovid. Emovid Corporation has introduced its Verified Human Communication platform, positioning the...
2d ago
EMOVI
PAYGo Credit Model Scrutinized as Off-Grid Energy Pushes Into Harder-to-Reach African Markets

PAYGo Credit Model Scrutinized as Off-Grid Energy Pushes Into Harder-to-Reach African Markets

According to a recent LinkedIn post from Acumen, the organization is drawing attention to evolving challenges in pay-as-you-go...
2d ago
ACUME
Tipalti Showcases Finance Automation and AI Focus at World Finance Forum London

Tipalti Showcases Finance Automation and AI Focus at World Finance Forum London

A LinkedIn post from Tipalti highlights the company’s participation at the World Finance Forum in London, where its...
2d ago
TIPAL
EquityZen Highlights Fee Structure and Risk Controls in Expanding Pre-IPO Market

EquityZen Highlights Fee Structure and Risk Controls in Expanding Pre-IPO Market

According to a recent LinkedIn post from EquityZen, the company is positioning its marketplace as a comparatively transparent...
2d ago
EQZNX
Healthcare Workforce Planning Trends Point to Rising Demand for Data-Driven Solutions

Healthcare Workforce Planning Trends Point to Rising Demand for Data-Driven Solutions

A LinkedIn post from Axuall highlights research on structural workforce challenges facing health systems and the limitations of...
2d ago
AXUAL
Axuall Highlights Healthcare Workforce Data Solutions on World Health Day

Axuall Highlights Healthcare Workforce Data Solutions on World Health Day

A LinkedIn post from Axuall connects World Health Day to the operational challenges facing healthcare systems that rely...
2d ago
AXUAL
Filevine Showcases Enterprise Legal Tech Adoption at Bass, Berry & Sims

Filevine Showcases Enterprise Legal Tech Adoption at Bass, Berry & Sims

A LinkedIn post from Filevine highlights its role as a technology partner for law firm Bass, Berry &...
2d ago
FILEV
Deccan AI Highlights Community Engagement and Conference Presence

Deccan AI Highlights Community Engagement and Conference Presence

According to a recent LinkedIn post from Deccan AI, the company is organizing a Spring Mixer event at...
2d ago
DECCA
Sparrow Showcases Illumio Case Study to Underscore Leave-Management Efficiency

Sparrow Showcases Illumio Case Study to Underscore Leave-Management Efficiency

According to a recent LinkedIn post from Sparrow, a benefits leader at Illumio is quoted describing a high...
2d ago
SPA42